CONGRESS ASSET MANAGEMENT CO

Position in RLAY — Relay Therapeutics, Inc.

CIK 897378 BOSTON, MA

Position in RLAY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$11,715,098

+$5,556,665 QoQ

Shares Held

626,141

+1.2% QoQ

Ownership

0.286%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#54

of 256 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

CONGRESS ASSET MANAGEMENT CO holds $715,705,658 across 14 Biotechnology names. RLAY ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	659,911	$208,591,267
2	TGTX	Tg Therapeutics, Inc.	2,600,123	$142,850,757
3	VCEL	Vericel Corp	2,916,295	$129,745,964
4	HALO	Halozyme Therapeutics, Inc.	1,229,106	$96,202,126
5	ALNY	Alnylam Pharmaceuticals, Inc.	265,701	$79,983,972
6	KRYS	Krystal Biotech, Inc.	40,134	$14,916,603
7	TNGX	Tango Therapeutics, Inc.	380,746	$11,902,119
8	RLAY	Relay Therapeutics, Inc. This page	626,141	$11,715,098

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,715,098	626,141	+1.2%	Shares	Sole	2026-07-07
2026-03-31	$6,158,433	618,938	+49.4%	Shares	Sole	2026-04-14
2025-12-31	$3,503,852	414,167	+1.3%	Shares	Sole	2026-01-09
2025-09-30	$2,134,155	408,842	+160.9%	Shares	Sole	2025-10-10
2025-06-30	$542,182	156,700	+0.3%	Shares	Sole	2025-07-16
2025-03-31	$409,249	156,202	-0.8%	Shares	Sole	2025-04-11
2024-12-31	$648,838	157,485	+7.6%	Shares	Sole	2025-01-30
2024-09-30	$1,036,681	146,424	-0.8%	Shares	Sole	2024-10-28
2024-06-30	$962,417	147,610	-1.0%	Shares	Sole	2024-08-02
2024-03-31	$1,237,380	149,082	+1.4%	Shares	Sole	2024-04-11
2023-12-31	$1,618,183	146,974	+0.4%	Shares	Sole	2024-03-04
2023-09-30	$1,231,509	146,434	+0.1%	Shares	Sole	2023-11-01
2023-06-30	$1,836,611	146,227	—	Shares	Sole	2023-07-27
No filing history on record for this holder in this stock.